Description

You need support with market access & health economic projects in the EU & UK. I am eager to support you in the creation of the following deliverables or any other HEMA elements based on your needs:

What?

• Value Dossier creation or adaptation

• Value Communication - Translating clinical and economic data into compelling value stories

• Coding guides creation

• Systematic literature review & meta-analysis

• Health economic modelling in excel

• Evidence gap analysis

• Reimbursement landscape scan

Why work with me?

• 16 years experience in the medical device industry

• Project lead of cross-functional international teams

• Latest methods from recent MSc in International Health Economics (Sheffield)

• Adapt to local teams & payer environments thanks to fluency in English, French, German, and Dutch

Recently delivered projects :

✅ Value dossier creation including systematic literature review & meta analysis, conceptual economic model, evidence gap analysis & reimbursement pathways for a neurosurgical device

✅ Communication campaign on a budget impact analysis and RWE publication for an infection prevention product (10% sales lift)

✅ Systematic literature review on wound dressing device

✅ Market sizing based on literature & procedural data in cardiology & ENT

✅ Mock Decision tree + Markov model with DSA/PSA in excel (antiplatelet therapy in ACS)

I bring a pragmatic, collaborative & results driven approach to every engagement.

If you have upcoming projects or would like to discuss how I can contribute, you can schedule a short call here:

📍 Based in Amsterdam | Available for projects across EU & UK on 10 hours per week basis

📬Phone:

Industry field of expertise

Languages

English
Native or bilingual
German
Native or bilingual
Dutch
Conversational
French
Native or bilingual

Workplace preferences

Can work on-site

Amsterdam (up to 50km)

BIOTRONIK,
Global Manager Marketing Strategy
PHARMACEUTICALS INDUSTRY
November 2011 - October 2013 (2 years)
Germany
• Management of global expert panel program (~100 customers, 10 annual meetings) i.e. organization and moderation of customer advisory boards, conduction of customer surveys and innovation workshops
• Moderation of the innovation assessment process (assessment of ~30 external & internal ideas, business case preparation & discussion with the executive board in quarterly meetings)
• Competitive intelligence analysis to support strategic decision making on board level
• Creation and implementation of a long-term strategy roadmap involving senior and executive leadership
Integra Lifesciences,
Senior Product & Market Access Manager EMEA
PHARMACEUTICALS INDUSTRY
March 2015 - Today (11 years and 2 months)
Netherlands
• Budget impact tool development & roll out to sales force
• RWE study publication, sales training & communication campaign for antibiotic impregnated catheters
• Systematic literature review for value dossier for wound care dressing
• Responsible market access Germany
• Creation of value dossier with conceptual model, HEOR requirements, study design and access pathways for Germany and UK – for surgical device used in haemorrhagic stroke
• Successful product launch execution involving 35 people across Europe including 10 different departments enabling 14% revenue growth in 2021 (forecasting, pricing, tender package, sales targeting & argumentation, objection handling, physician education program, campaign development, communication plan)
• Upstream Marketing: conduction of market studies & advisory boards (~200 customers)
• Downstream Marketing: Leading a multicultural cross-functional team of 15 in the last 5 years and enabling them to create and implement about 5 new marketing initiatives annually (e.g. payer pricing strategies, creation of strategic marketing plans, clinical marketing campaigns, sales training, challenger messages)
Life Partners Europe,
Sales representative
PHARMACEUTICALS INDUSTRY
January 2009 - October 2011 (2 years and 10 months)
France
• Executed sales and export management for endoscopy medical devices
• Specialized in clinical field support for innovative technologies for radiofrequency ablation, digestive implants, and endoscopic closure systems